7-26152650-G-T
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_004289.7(NFE2L3):c.152G>T(p.Gly51Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000279 in 1,506,454 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G51C) has been classified as Uncertain significance.
Frequency
Consequence
NM_004289.7 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 151962Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00 AC: 0AN: 105068 AF XY: 0.00
GnomAD4 exome AF: 0.0000273 AC: 37AN: 1354492Hom.: 0 Cov.: 31 AF XY: 0.0000254 AC XY: 17AN XY: 669554 show subpopulations
GnomAD4 genome AF: 0.0000329 AC: 5AN: 151962Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74240 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.152G>T (p.G51V) alteration is located in exon 1 (coding exon 1) of the NFE2L3 gene. This alteration results from a G to T substitution at nucleotide position 152, causing the glycine (G) at amino acid position 51 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at